We are live on ! Find out more
TVTX icon

Travere Therapeutics
TVTX

175 hedge funds and large institutions have $677M invested in Travere Therapeutics in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 64 increasing their positions, 48 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 21

33% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 48

6% more funds holding

Funds holding: 165 → 175 (+10)

4.07% less ownership

Funds ownership: 119.41% → 115.35% (-4.1%)

16% less capital invested

Capital invested by funds: $807M → $677M (-$129M)

81% less call options, than puts

Call options by funds: $1.09M | Put options by funds: $5.82M

Holders
175
Holders Change
+10
Holders Change %
+6.06%
% of All Funds
2.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
64
Reduced
48
Closed
21
Calls
$1.09M
Puts
$5.82M
Net Calls
-$4.73M
Net Calls Change
+$1.55M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$10.6M
2
EP
Eversept Partners
New York
+$8.06M
3
Millennium Management
Millennium Management
New York
+$7.65M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$7.36M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$6.33M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$40M
2
FCM
Farallon Capital Management
California
-$9.84M
3
APM
Avidity Partners Management
Texas
-$7.43M
4
Goldman Sachs
Goldman Sachs
New York
-$6.51M
5
WP
Woodline Partners
California
-$5.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
$1.19M -$710K -84,172 -35%
Swiss National Bank
52
Swiss National Bank
Switzerland
$1.14M – – –
AAA
53
Affinity Asset Advisors
New York
$964K +$1.05M +125,000 New
State of Wisconsin Investment Board
54
State of Wisconsin Investment Board
Wisconsin
$945K +$248K +29,349 +31%
BC
55
Birchview Capital
Vermont
$941K – – –
Man Group
56
Man Group
United Kingdom
$907K +$992K +117,601 New
PAI
57
Palo Alto Investors
California
$854K – – –
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$825K -$10.3K -1,221 -1%
Schroder Investment Management Group
59
Schroder Investment Management Group
United Kingdom
$805K +$881K +104,377 New
Mirae Asset Global Investments
60
Mirae Asset Global Investments
South Korea
$804K +$31.7K +3,754 +8%
UBS AM
61
UBS AM
Illinois
$802K +$38.4K +4,555 +5%
CS
62
Credit Suisse
Switzerland
$792K +$6.46K +766 +0.8%
Los Angeles Capital Management
63
Los Angeles Capital Management
California
$720K +$788K +93,417 New
PA
64
Profund Advisors
Maryland
$707K +$188K +22,247 +32%
Susquehanna International Group
65
Susquehanna International Group
Pennsylvania
$687K +$525K +62,215 +232%
Public Sector Pension Investment Board (PSP Investments)
66
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$671K – – –
CM
67
Crestline Management
Texas
$647K +$20.9K +2,476 +3%
PCM
68
Prelude Capital Management
New York
$635K +$456K +54,000 +190%
LPC
69
Lion Point Capital
New York
$601K – – –
Fidelity Investments
70
Fidelity Investments
Massachusetts
$585K -$8.74K -1,036 -1%
Legal & General Group
71
Legal & General Group
United Kingdom
$579K -$504K -59,699 -44%
California State Teachers Retirement System (CalSTRS)
72
California State Teachers Retirement System (CalSTRS)
California
$577K -$33.2K -3,930 -5%
RHJA
73
Rice Hall James & Associates
California
$566K +$26.5K +3,140 +4%
JF
74
Jump Financial
Illinois
$548K +$436K +51,687 +266%
Norges Bank
75
Norges Bank
Norway
$547K – – –
1 2
3
4 5

TVTX Hedge Fund Activity: Q1 2024 in Review

175 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q1 2024, worth a combined $677M — down 16% from $807M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new TVTX positions and 21 closed out — a net gain of 10 holders — while 64 added to existing stakes and 48 trimmed.

The largest buyer was State Street, adding an estimated $10.6M. The largest seller was Morgan Stanley, cutting an estimated $40M.

  • 175 institutional investors held Travere Therapeutics (TVTX) as of Q1 2024, up from 165 in Q4 2023.
  • Funds reported $677M of Travere Therapeutics stock for Q1 2024, down 16% quarter-over-quarter.
  • 31 funds opened new Travere Therapeutics positions in Q1 2024 and 21 closed out, a net change of +10 holders.
  • The largest Travere Therapeutics buyer in Q1 2024 was State Street, an estimated $10.6M added.
  • The largest Travere Therapeutics seller in Q1 2024 was Morgan Stanley, an estimated $40M sold.

Based on aggregated 13F filings for Q1 2024.